These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11851514)
1. Preventing type 1 diabetes may someday become possible. Vastag B JAMA; 2002 Feb; 287(6):701-2. PubMed ID: 11851514 [No Abstract] [Full Text] [Related]
2. [Pharmacotherapies for type 1 diabetes mellitus]. Maruyama T Nihon Rinsho; 2002 Sep; 60 Suppl 9():190-5. PubMed ID: 12386992 [No Abstract] [Full Text] [Related]
4. Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial results. Eldor R; Kassem S; Raz I Diabetes Metab Res Rev; 2009 May; 25(4):316-20. PubMed ID: 19267355 [TBL] [Abstract][Full Text] [Related]
5. For parents. Type 1 diabetes research. Balancing hope with realism. Dinsmoor RS Diabetes Self Manag; 2003; 20(2):87-8, 91-2, 95, 99-102. PubMed ID: 12715738 [No Abstract] [Full Text] [Related]
6. Prevention and treatment of type I diabetes in NOD mice by linomide. Slavin S; Gross D; Weiss L Transplant Proc; 1995 Dec; 27(6):3240. PubMed ID: 8539933 [No Abstract] [Full Text] [Related]
7. Prevention of type 1 diabetes: where do we start? Pozzilli P; Adorini L J Endocrinol Invest; 2003 Apr; 26(4):292-3. PubMed ID: 12841534 [No Abstract] [Full Text] [Related]
9. [Experimental and clinical study of a new immunoregulator preparation thymalin]. Khavinson VKh; Morozov VG Voen Med Zh; 1982 May; (5):37-9. PubMed ID: 7048731 [No Abstract] [Full Text] [Related]
10. Immuno-intervention and preservation of beta-cell function in type 1 diabetes. Pozzilli P Diabetes Metab Res Rev; 2007 May; 23(4):255-6. PubMed ID: 17476663 [No Abstract] [Full Text] [Related]
11. Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D-glucan and rhIGF-I. Kida K; Kaino Y; Ito T; Hirai H J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():327-33. PubMed ID: 9642663 [No Abstract] [Full Text] [Related]
12. DiaPep277® and immune intervention for treatment of type 1 diabetes. Schloot NC; Cohen IR Clin Immunol; 2013 Dec; 149(3):307-16. PubMed ID: 24090708 [TBL] [Abstract][Full Text] [Related]
13. [Principles and perspectives of immunomodulation in the treatment of diabetes mellitus type I]. Majkowska L; Czekalski S Pol Tyg Lek; 1989 May 22-29; 44(21-22):509-12. PubMed ID: 2702343 [No Abstract] [Full Text] [Related]
14. Linomide, a new treatment for autoimmune diseases: the potential in type 1 diabetes. Slavin S; Sidi H; Weiss L; Rosenman E; Kalland T; Gross D Diabetes Metab Rev; 1993 Dec; 9(4):311-5. PubMed ID: 7924828 [No Abstract] [Full Text] [Related]
15. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity. Quintana FJ; Rotem A; Carmi P; Cohen IR J Immunol; 2000 Dec; 165(11):6148-55. PubMed ID: 11086048 [TBL] [Abstract][Full Text] [Related]
16. [Immunomodulating therapy in insulin-dependent diabetes mellitus: problems and new prospects]. Galenok VA; Zhuk EA Ter Arkh; 1995; 67(12):80-4. PubMed ID: 8820069 [No Abstract] [Full Text] [Related]
20. [The characteristics of the immunogenesis and immunocorrection of diabetes mellitus]. Galenok VA; Zhuk EA Ter Arkh; 1995; 67(10):7-12. PubMed ID: 8779114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]